“acute-myeloid-leukemia” Archives

in
Entry Author Date Location
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue 09/09/20 National
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs 09/27/19 Boston
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push 10/19/18 San Diego
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More 08/04/17 National
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More 05/05/17 National
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold 03/06/17 Seattle
Bellicum, Molecular Templates Granted $32M for Immuno-Oncology Work 11/17/16 Texas
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma 05/31/16 New York
UW Health Surgeon’s Startup Expanding Software to Monitor Patients 05/27/16 Wisconsin
Tech Megatransfer: Merck Pays Harvard $20M For “Accelerated” Cancer Drugs 03/21/16 Boston
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Stanford Spins Out Immunotherapy Work Funded By CIRM’s Millions 02/25/16 San Francisco
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
Page 1 of 3 next page »